oqory,

Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqorys TROP2 Antibody Drug Conjugate, OQY-3258Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqorys TROP2 Antibody Drug Conjugate, OQY-3258

Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqorys TROP2 Antibody Drug Conjugate, OQY-3258

SAN MATEO, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address…

3 months ago
Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.

Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.

PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address…

4 months ago
Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.

Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.

PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address…

4 months ago
Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.

Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.

PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address…

4 months ago